Bilikere S Dwarakanath (B S Dwarakanath)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

Cancer reports (Hoboken, N.J.)

Cancer management and research

International journal of radiation biology

Autophagy

Shanghai Proton and Heavy Ion Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shanghai Proton and Heavy Ion Center Sep 18 2017

China

Senior Principal Investigator :: Research and Development

Sri Ramachandra University

India

Professor

DRDO Institute of Nuclear Medicine and Allied Sciences

India

Scientist

Publications

Akhil Pulumati, Anika Pulumati, Bilikere S Dwarakanath, Amit Verma, Rao V L Papineni
Technological advancements in cancer diagnostics: Improvements and limitations. Cancer reports (Hoboken, N.J.) 6 (2) (2023)
Akhil Pulumati, Anika Pulumati, Bilikere S Dwarakanath, Amit Verma, Rao V L Papineni
Technological advancements in cancer diagnostics: Improvements and limitations. Cancer reports (Hoboken, N.J.) 6 (2) (2023)
Akhil Pulumati, Anika Pulumati, Bilikere S Dwarakanath, Amit Verma, Rao V L Papineni
Technological advancements in cancer diagnostics: Improvements and limitations. Cancer reports (Hoboken, N.J.) 6 (2) (2023)
Akhil Pulumati, Anika Pulumati, Bilikere S Dwarakanath, Amit Verma, Rao V L Papineni
Technological advancements in cancer diagnostics: Improvements and limitations. Cancer reports (Hoboken, N.J.) 6 (2) (2023)
Akhil Pulumati, Anika Pulumati, Bilikere S Dwarakanath, Amit Verma, Rao V L Papineni
Technological advancements in cancer diagnostics: Improvements and limitations. Cancer reports (Hoboken, N.J.) (2023)
Akhil Pulumati, Anika Pulumati, Bilikere S Dwarakanath, Amit Verma, Rao V L Papineni
Technological advancements in cancer diagnostics: Improvements and limitations. Cancer reports (Hoboken, N.J.) (2023)
Amit Verma, Aastha Arora, Anant N Bhatt, Mohan B Arya, Ashok K Prasad, Virinder S Parmar, Bilikere S Dwarakanath
Radiosensitization of calreticulin-overexpressing human glioma cell line by the polyphenolic acetate 7, 8-diacetoxy-4-methylcoumarin. Cancer reports (Hoboken, N.J.) (2021)
Amit Verma, Amitava Adhikary, Gayle E Woloschak, Bilikere S Dwarakanath, Rao V L Papineni
A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management. International journal of radiation biology 96 (11) (2020)
Madhuri Chaurasia, Swapnil Gupta, Asmita Das, Bilikere S Dwarakanath, Anne Simonsen, Kulbhushan Sharma
Radiation induces EIF2AK3/PERK and ERN1/IRE1 mediated pro-survival autophagy. Autophagy 15 (8) (2019)
Amit Verma, Rohit Mathur, Abdullah Farooque, Vandana Kaul, Seema Gupta, Bilikere S Dwarakanath
T-Regulatory Cells In Tumor Progression And Therapy. Cancer management and research 11 (2019)

Bilikere S Dwarakanath.css-eqlu8i{font-size:small;padding-left:4px;} (B S Dwarakanath)

Publication Activity (10 Years)

Top Topics

Top Venues

Bilikere S Dwarakanath (B S Dwarakanath)